End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
836.2 INR | +1.68% | -0.47% | +27.27% |
May. 15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
Apr. 25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GLENMARK LIFE SCIENCES LIMITED | Other Pharmaceuticals | +1.68% | -0.47% | +27.27% | +54.72% | - | 1.23B |
Technical Rankings Surperformance
- Stock Market
- Equities
- GLS Stock
- Charts Glenmark Life Sciences Limited
- Comparison Chart